Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $78.00 at Barclays
Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) had its price target increased by equities researchers at Barclays from $50.00 to $78.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 31.82% from the stock’s current price. ORKA has [...]